Antonio Noguera1, Carlos Centeno, Silvia Librada, María Nabal. 1. Palliative Care Unit, Hospital Centro de Cuidados Laguna, C/ Concejal Francisco José Jiménez Martín 128, Madrid 28047, Spain. anoguera@lagunacuida.org
Abstract
OBJECTIVES: This study was aimed at evaluating the clinical use of laxatives in palliative care treatment, their overall effectiveness, and their relationship to opioid treatment. POPULATION AND METHOD: A cross-sectional prospective study on patients attended by 21 palliative care teams on two pre-determined dates was carried out. The variables analyzed were demographic data, underlying disease, functional status, laxative use, use of enemas, concomitant opioid medication, and bowel movements. RESULTS: Of the 283 patients studied, 54 (19%) have had three or fewer bowel movements per week in the 3 weeks prior to the study, 53 patients (19%) were using rectal measures, 177 patients (63%) were being treated with opioids, and 164 patients (58%) were taking laxatives. Sixty seven percent (119/177) of the patients being treated with opioids were also being treated with laxatives, as were 43% (45/106) of those not receiving opioid treatment. The laxative most used was lactulose (65%). Only 10% used the most recommended combination of an osmotic or softener laxative mixed with another stimulant laxative. Some 24% of patients used enemas or micro enemas in addition to laxatives, 14 patients treated their constipation without laxatives, using only rectal measures. CONCLUSION: The clinical practice of the use of oral laxatives in palliative care in our environment differs widely from that recommended in the literature. Further studies are required to confirm if a revision of clinical guidelines are required.
OBJECTIVES: This study was aimed at evaluating the clinical use of laxatives in palliative care treatment, their overall effectiveness, and their relationship to opioid treatment. POPULATION AND METHOD: A cross-sectional prospective study on patients attended by 21 palliative care teams on two pre-determined dates was carried out. The variables analyzed were demographic data, underlying disease, functional status, laxative use, use of enemas, concomitant opioid medication, and bowel movements. RESULTS: Of the 283 patients studied, 54 (19%) have had three or fewer bowel movements per week in the 3 weeks prior to the study, 53 patients (19%) were using rectal measures, 177 patients (63%) were being treated with opioids, and 164 patients (58%) were taking laxatives. Sixty seven percent (119/177) of the patients being treated with opioids were also being treated with laxatives, as were 43% (45/106) of those not receiving opioid treatment. The laxative most used was lactulose (65%). Only 10% used the most recommended combination of an osmotic or softener laxative mixed with another stimulant laxative. Some 24% of patients used enemas or micro enemas in addition to laxatives, 14 patients treated their constipation without laxatives, using only rectal measures. CONCLUSION: The clinical practice of the use of oral laxatives in palliative care in our environment differs widely from that recommended in the literature. Further studies are required to confirm if a revision of clinical guidelines are required.
Authors: Bruce H Chamberlain; Karen Cross; Jaron L Winston; Jay Thomas; Wenjin Wang; Chinyu Su; Robert J Israel Journal: J Pain Symptom Manage Date: 2009-08-26 Impact factor: 3.612
Authors: Jay Thomas; Sloan Karver; Gail Austin Cooney; Bruce H Chamberlain; Charles Kevin Watt; Neal E Slatkin; Nancy Stambler; Alton B Kremer; Robert J Israel Journal: N Engl J Med Date: 2008-05-29 Impact factor: 91.245
Authors: Lars Morten Skollerud; Olav Ms Fredheim; Kristian Svendsen; Svetlana Skurtveit; Petter C Borchgrevink Journal: Support Care Cancer Date: 2012-06-01 Impact factor: 3.603
Authors: Andrew Davies; Charlotte Leach; Ricardo Caponero; Andrew Dickman; David Fuchs; Judith Paice; Anton Emmanuel Journal: Support Care Cancer Date: 2019-08-09 Impact factor: 3.603
Authors: Bridget Candy; Louise Jones; Philip J Larkin; Victoria Vickerstaff; Adrian Tookman; Patrick Stone Journal: Cochrane Database Syst Rev Date: 2015-05-13